FORM 4
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Check this box if no longer
subject to Section 16. Form 4
or Form 5 obligations may
continue. See Instruction 1(b)
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 of Section
30(f) of the Investment Company Act of 1940
<TABLE>
<S> <C>
- ------------------------------------------------------------------ -----------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
LifePoint, Inc. - LFPT
Name and Address of Reporting Person
Foley Thomas J.
____________________________________________________________
(Last) (First) (Middle)
10400 Trademark Street
(Street)
Rancho Cucamonga, CA 91730
City (State) (Zip)
- ------------------------------------------------------------------ -----------------------------------------------------------------
- ------------------------------------------------------------------ ------------------------- ---------------------------------------
<C> <C>
3. IRS or Social 4. Statement for Month/Year
Security
Number of Reporting 10/99
Person (Voluntary)
###-##-####
- ------------------------------------------------------------------ ------------------------- ---------------------------------------
- ------------------------------------------------------------------ ------------------------- ---------------------------------------
<C>
5. If Amendment, Date of Original
(Month/Year)
- ------------------------------------------------------------------ ------------------------- ---------------------------------------
- ------------------------------------------------------------------ -----------------------------------------------------------------
<C>
----------------------------------------------
6. Relationship of Reporting Person to
Issuer
(Check if Applicable)
__ Director ___ 10% Owner
X Officer (give ___
Other (specify
title below)
below)
Senior Vice President, Research and Development
----------------------------------------------
----------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ---------------------------------------------------------- -----------------------------------------------------------------------
- ---------------------------------------------------------- ------------------- ------------------ --------------------------------
<S> <C> <C> <C>
1. Title of Security 2. Transaction 3. Transaction 4. Securities Acquired (A) or
(Instr. 3) Date Code Disposed of (D) (Instr. 3, 4,
(Month/Day/Year) (Instr. 8) and 5)
- ---------------------------------------------------------- ------------------- ------------------ --------------------------------
- ---------------------------------------------------------- ------------------- ---------- ------- ----------- --------- ----------
Code V Amount (A) or Price
(D)
- ---------------------------------------------------------- ------------------- ---------- ------- ----------- --------- ----------
- ---------------------------------------------------------- ------------------- ---------- ------- ----------- --------- ----------
None
- ---------------------------------------------------------- ------------------- ---------- ------- ----------- --------- ----------
- ---------------------------------------------------------- ------------------- ---------- ------- ----------- --------- ----------
- -------------------------------------------
- --------------- ----------- ---------------
<C> <C> <C>
5. Amount of 6. 7. Nature of
Securities Owner-ship Indirect
Beneficially Form: Beneficially
Owned at End Direct Ownership
of Month (D) or (Instr. 4)
(Instr. 3 and Indirect
4) (I)
(Instr. 4)
- --------------- ----------- ---------------
- --------------- ----------- ---------------
- --------------- ----------- ---------------
- --------------- ----------- ---------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<TABLE>
<CAPTION>
Form 4 (continued) Table II - Derivative Securities Acquired, Disposed of, or
Beneficially Owned (e.g., puts, calls, warrants, options, convertible
securities)
<S> <C> <C> <C> <C>
- ---------------------------- ------------- -------------- -------------- ---------------
1. Title of Derivative 2. Conver- 3. 4. 5. Number of
Security (Instr. 3) sion or Transaction Transaction Derivation
Exercisable Date Code (Instr. Securities
Price of (Month/Day/Year8) Acquired (A)
Derivative or Disposed
Security of (D)
(Instr. 3,4,
and 5)
- ---------------------------- ------------- -------------- -------------- ---------------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
Code V (A) (D)
- ---------------------------- ------------- -------------- ------ ------- -------- ------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
Stock Option $1.72 10/10/99 A 60,000 0
- ---------------------------- ------------- -------------- ------ ------- -------- ------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
Common Stock Purchase $1.72 10/10/99 A 1 0
Warrant
- ---------------------------- ------------- -------------- ------ ------- -------- ------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
Common Stock Purchase $1.72 10/10/99 A 1 0
Warrant
- ---------------------------- ------------- -------------- ------ ------- -------- ------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
- ---------------------------- ------------- -------------- ------ ------- -------- ------
<S> <C> <C> <C> <C> <C>
- ----------------- ------------------------ ------------- ------------- ----------- -----------
6. Date 7. Title and Amount of 8. Price of 9. Number 10. 11.
Exercisable and Underlying Securities Derivative of Ownership Nature of
Expiration Date (Instr. 3 and 4) Security Derivative Form of Indirect
(Month/Date/Year) (Instr. 5) Securities Derivative Beneficial
Beneficially Security: Ownership
Owned at Direct (Instr. 4)
end of (D) or
month Indirect
(Instr. 4) (I)
(Instr. 4)
- ----------------- ------------------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
Date Expiration Title Amount or
Exercisable Date Number of
Shares
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
(1) 10/9/09 Common 60,000 0 260,000 D N/A
Stock
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
(2) (3) Common 250,000 0 510,000 D N/A
Stock
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
(4) (5) Common 250,000 0 760,000 D N/A
Stock
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
- -------- -------- ----------- ------------ ------------- ------------- ----------- -----------
</TABLE>
Explanation of Responses:
(1) Option becomes exercisable as to 15,000 shares on 10/10/00, and as to 1,250
shares on the 10th of each month for 36 months thereafter.
(2) Warrant becomes exercisable only if the Issuer derives revenues of $100,000
from third-party sales of its saliva based testing product prior to January 1,
2001.
(3) The earlier of the 5th anniversary of the day before the day on which
$100,000 in sales is made or December 31, 2005.
(4) Warrant becomes exercisable only if Issuer files an application to the Food
and Drug Administration (the "FDA") before January 1, 2001 and the Reporting
Person holds the same position on such date.
(5) The earlier of the day before the 5th anniversary of the day before the day
on which an application to the FDA is submitted or December 31, 2005.
/s/ Thomas J. Foley 11/5/99
----------------------------------- -------
Signature of Reporting Person Date
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, See Instruction 6 for procedure.
